Humane endpoints in vaccine potency testing

Procedia in Vaccinology

Volumn 5, Issue , 2011, Pages 221-226

  Hendriksen, Coenraad F M ^a,b  

^a NETHERLANDS VACCINE INSTITUTE   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Humane endpoints; Vaccine potency testing

Indexed keywords

DIPHTHERIA TETANUS VACCINE; TETANUS TOXOID;

ARTICLE; BODY POSTURE; BODY TEMPERATURE; BODY WEIGHT; BORDETELLA PERTUSSIS; CASE STUDY; CAUSE OF DEATH; CONVULSION; DISTRESS SYNDROME; DRUG POTENCY; DYING; IMMUNIZATION; LETHAL DOSE; MEDICAL LITERATURE; NONHUMAN; OBSERVATION; PAIN; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; REFLEX; RELIABILITY; SEROLOGY;

EID: 84555217930     PISSN: None     EISSN: 1877282X     Source Type: Journal    
DOI: 10.1016/j.provac.2011.10.022     Document Type: Article

References (10)

1. Zo doende 2009. Jaaroverzicht van de Voedsel en Waren Autoriteit over dierproeven en proefdieren (Annual report of the Food Safety Authority about animal experimentation and laboratory animals). VWA, 2010 The Netherlands (http://www.vwa.nl/).
2. Hendriksen C, Morton D, Cussler K. Use of humane endpoints to minimise suffering. In: The COST Manual of Laboratory AnimalCare and Use. Refinement, Reduction and Research. Eds. Howard B, Nevalainen T and Perreta G. CRC Press, Boca Raton, US. ISBN 978-1-4398-2492-4, 2011:333-355.
3. European Commission. Directive 2010/63/EU on the Protection of Animals Use for Scientific Purposes. Official Journal of the European Union, 20.10.2010, L276/33.
4. Winsnes R., Hendriksen C. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use. Pharmeuropa Bio 2000, 1:83-124.
5. Winsnes R., Sesardic D., Daas A., Behr-Gross M.E. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccine (part 2). Pharmeuropa Bio 2006, 1:73-88.
6. USDA, Animal Welfare. Final Rules: CFR, Title 9, Animals and Animal Products, Part 117 Animals at Licensed Establishments, 117.4 (e) - Test animals Animals and Animal Products, 1998 page 813.
7. Von Hunolstein C., Gomez Miguel M.J., Pezzella C., Scopetti F., Behr-Gross M.E., Halder M., Hoffmann S., Levels L., van der Gun J., Hendriksen C. Evaluation of two serological methods for potency testing of whole cell pertussis vaccines. Pharmeuropa Bio 2008, 1:7-18.
8. Kendrick P.L., Eldering G. A study in active immunization against pertussis. Am J Hyg 1939, 29:133-153.
9. Hendriksen CFM, Steen B, Visser J, Cussler K, Morton D & Streijger F. The evaluation of humane endpoints in pertussis vaccine potency testing. In: Humane Endpoints in Animal Experiments for Biomedical Research. Hendriksen CFM & Morton DB (eds). The Royal Society Medicine Press, London (UK). 1999:106-113.
10. Cussler K, Morton DB & Hendriksen CFM. Possibilities for the use of humane endpoints in vaccine potency tests. In: Progress in the Reduction, Refinement and Replacement of Animal Experimentation. Balls M, Van Zeller A-M & Halder M. (eds.). Elsevier, Amsterdam, 2000:915-927.